Escaldi Steven
Spasticity Management Program, Department of Rehabilitation Medicine, JFK-Johnson Rehabilitation Institute, Edison, NJ 08818, USA; Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Phys Med Rehabil Clin N Am. 2018 Aug;29(3):519-527. doi: 10.1016/j.pmr.2018.03.005. Epub 2018 Jun 4.
The key to the successful treatment of patients with spasticity is contingent on choosing appropriate interventions tailored to meet the needs, goals, and specific presentation of each patient. For the clinician attempting to address the focal manifestations of hypertonia without surgical intervention, there have been 2 primary options: neurolysis or chemodenervation. Before the introduction of the botulinum toxins, neurolysis was the only focal spasticity treatment option available to the previous generation of physical medicine and rehabilitation practitioners.
成功治疗痉挛患者的关键取决于选择适合每个患者需求、目标和具体表现的适当干预措施。对于试图在不进行手术干预的情况下解决局部张力亢进表现的临床医生来说,有两种主要选择:神经松解术或化学去神经支配术。在肉毒杆菌毒素出现之前,神经松解术是上一代物理医学与康复从业者唯一可用的局部痉挛治疗选择。